FIG 1.
REMARK diagram shows 2,338 eligible B-42 patients with available biospecimens. Insufficient quantity and quality of RNA excluded 472 tumors leading to a final translational MammaPrint cohort of 1,866 patients.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.